Allele Biotechnology & Pharmaceuticals, Inc. (Allele), a San Diego-based technology development and cell manufacturing company, today announced its participation in an up to $25.8 million research ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...

Panelists discuss how emerging therapies—including TKIs, sustained-release implants, and gene therapy—may reduce treatment ...

Cleveland Browns legendary quarterback Bernie Kosar has been re-admitted to the hospital to the fourth time following his ...

CUIMC’s Dr. Maureen McKiernan, with an assist from Dr. Andrew Goldstone, performs surgery on the “ragged edge of what’s ...

In the year after surgery for primary congenital glaucoma, rigid gas-permeable contact lenses led to significantly better ...

Kochi: For the first time in the country, Ernakulam General Hospital (GH) performed a heart transplant surgery at a district-level hospital on Monday. The heart of S Shibu, 46, of Kollam, who was ...

New research from the University of Minnesota Medical School offers a new view of how the immune system responds to organ ...

When Anthony Guacci walked into Atrium Health Carolinas Medical Center last fall, he had no idea how close he was to the end ...

For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has ...

OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, and a panel of experts examined a series of unusual ...